Leberkrebszentrum Barmherzige Brüder Regensburg Prüfeninger Straße 86 93049 Regensburg DeutschlandNoch nicht rekrutierend» Google-Maps Ansprechpartner: Oliver Pech» Ansprechpartner anzeigenWestmead hospital Sydney AustraliaNoch nicht rekrutierend» Google-Maps Ansprechpartner: M. Bourke, MD, PhD» Ansprechpartner anzeigenUZ Gasthuisberg Leuven BelgiumRekrutierend» Google-Maps Ansprechpartner: R. Bisschops, MD, PhD» Ansprechpartner anzeigenCHU Nantes Nantes FranceNoch nicht rekrutierend» Google-Maps Ansprechpartner: Emmanuel Coron» Ansprechpartner anzeigenAmsterdam UMC, location VUmc Amsterdam NetherlandsAbgeschlossen» Google-MapsCatharina Hospital Eindhoven NetherlandsAbgeschlossen» Google-MapsUniversity Medical Center Groningen Groningen NetherlandsAbgeschlossen» Google-MapsSt. Antonius Hospital Nieuwegein NetherlandsAbgeschlossen» Google-MapsErasmus MC - University Medical Center Rotterdam NetherlandsAbgeschlossen» Google-MapsHaga Medical Center The Hague NetherlandsAbgeschlossen» Google-MapsIsala Clinics Zwolle NetherlandsAbgeschlossen» Google-MapsHirslanden private hospital group Zürich SwitzerlandRekrutierend» Google-Maps Ansprechpartner: S. Seewald» Ansprechpartner anzeigenUniversity College London Hospital London United KingdomNoch nicht rekrutierend» Google-Maps Ansprechpartner: R. Haidry, MD, PhD» Ansprechpartner anzeigen
1. lymph node metastasis rate (Time Frame - 10 years): Confirmed by cytology and/or histology by performing FNA during EUS or biopsies
2. distant metastasis rate (Time Frame - 10 years): Primary tumor of distant metastasis should be histopathologically evalueted by taking biopsies.
3. disease-specific mortality (Time Frame - 10 years): Disease specific mortality is decribed as mortality directly linked to the esophageal adenocarcinoma (i.e., metastasized EAC, metastasized disease with a simultaneously primary cancer present and it cannot be ruled out (based on histology) that the metastases are related to the other primary cancer, death due to complications of the endoscopic procedure, death due to complications after surgery or CRT, no clear cause of death in patients who have metastases or untreated local recurrence). If patients are diagnosed with distant metastases, and subsequently die of a non-tumor related cause, patients will still be documented as tumor-related death. Will be measured in number of patients and percentages. Survival analysis using Kaplan Meier will be performed.
4. overall mortality (Time Frame - 10 years): Overall mortality of study population (tumor-related + non-tumor-related deaths). Measured in numbers and percentages, survival analysis (KM).